TriSalus Life Sciences® Inc., an oncology company specializing in novel delivery technologies combined with immunotherapy for liver and pancreatic...

Volastra Therapeutics, a clinical-stage biotechnology company at the forefront of developing cancer treatments targeting chromosomal instability (CIN), has announced...

Bristol Myers Squibb (BMY) has launched a $1.8 million initiative to advance health equity by addressing the social determinants...

In the fast-changing world of pharmaceutical drug development, new digital twin technologies are beginning to make a significant impact....

Arrowhead Pharmaceuticals, Inc. has launched an Expanded Access Program (EAP) to offer plozasiran, its investigational therapy, to patients with...

Actylis and Novo Nordisk Pharmatech A/S have partnered to distribute pharmaceutical-grade Benzalkonium Chloride (BKC) in key European markets, including...

Verge Genomics and Ferrer have embarked on a strategic partnership to advance the development and potential commercialization of VRG50635,...

The clinical trial industry faces a critical juncture as the dust settles from the COVID-19 pandemic. During the height...

Gilead Sciences, Inc. has finalized its acquisition of CymaBay Therapeutics, Inc. for an approximate total equity value of $4.3...

Esperion has announced a pivotal development in cardiovascular treatment, with the FDA approving broad label expansions for NEXLETOL® (bempedoic...